AFFAMED

AffaMed Therapeutics is a late clinical-stage biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs in ophthalmology. We hope to bring the benefit of our products to patients in Greater China and around the world... We are advancing a strong group of innovative clinical assets in ophthalmology. These drug candidates provide us a risk-balanced portfolio in a mix of major disease states characterized by high unmet patient needs.

Also known as: AffaMed Therapeutics

Primary location: Shanghai P.r.c.